Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Donovan Joanne M. | CMO | 2026-08-13 | 2,919 | $126,704 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 5,781 | $0 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 7,500 | $0 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 2,171 | $95,075 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 304 | $13,529 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 150 | $6,666 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | 2,475 | $108,154 |
| Donovan Joanne M. | CMO | 2026-08-12 | 5,781 | $0 |
| Donovan Joanne M. | CMO | 2026-08-12 | 7,031 | $0 |
| Donovan Joanne M. | CMO | 2026-08-12 | 2,839 | $124,303 |
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | VANGUARD CAPITAL MANAGEMENT LLC increased this position by 31% ($119,327,072 -> $156,859,022). | 2026-06-30 |
| FMR LLC | FMR LLC increased this position by 237% ($32,028,980 -> $107,911,899). | 2026-06-30 |
| ORBIMED ADVISORS LLC | ORBIMED ADVISORS LLC increased this position by 29% ($488,832,498 -> $630,516,330). | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | PERCEPTIVE ADVISORS LLC increased this position by 28% ($139,355,181 -> $177,714,564). | 2026-06-30 |
| NOVO HOLDINGS A/S | NOVO HOLDINGS A/S increased this position by 29% ($168,525,000 -> $217,370,500). | 2026-06-30 |
| Integral Health Asset Management, LLC | Integral Health Asset Management, LLC increased this position by 61% ($50,400,000 -> $81,260,000). | 2026-06-30 |
| Paradigm Biocapital Advisors LP | Paradigm Biocapital Advisors LP increased this position by 79% ($231,998,697 -> $415,053,937). | 2026-06-30 |
| Driehaus Capital Management LLC | Driehaus Capital Management LLC increased this position by 36% ($141,055,173 -> $192,123,952). | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | $630,516,330 | 15,518,492 |
| Paradigm Biocapital Advisors LP | $415,053,937 | 10,215,455 |
| RA CAPITAL MANAGEMENT, L.P. | $340,996,620 | 8,392,730 |
| NOVO HOLDINGS A/S | $217,370,500 | 5,350,000 |
| Driehaus Capital Management LLC | $192,123,952 | 4,728,623 |
| PERCEPTIVE ADVISORS LLC | $177,714,564 | 4,373,974 |
| VANGUARD CAPITAL MANAGEMENT LLC | $156,859,022 | 3,860,670 |
| BAKER BROS. ADVISORS LP | $150,400,843 | 3,701,719 |
| Siren, L.L.C. | $129,391,476 | 3,184,629 |
| FMR LLC | $107,911,899 | 2,655,966 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
Soleus Capital Management, L.P. is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This profile tracks those disclosures over time, giving a running record of the fund’s reported buys, sells, and position size changes as new 13F data becomes available. Because 13F filings only capture a quarterly … Read more